The presbyopia debate

Article

During the "Controversies in Cataract and Refractive Surgery" symposium, Dr Jack Holladay and Dr Theo Seiler debated the relative merits of presbyopia treatments.

During the “Controversies in Cataract and Refractive Surgery” symposium, Dr Jack Holladay and Dr Theo Seiler debated the relative merits of presbyopia treatments.

Dr Holladay argued that the ACI7000 corneal inlay (Acufocus, Inc.), which utilizes the pinhole effect to reduce the pupil size to 1.6 mm, improves the depth of field without impacting the cornea, and cited the initial 41 Acufocus implantations in Turkey; two years later, patients have 20/16 vision at near and distance, and the operating surgeon is satisfied with the results.

Dr Seiler countered by discussing the cosmetic and low light issues some patients have had with the Acufocus. He noted that we assume that what we know about the multifocality or asphericity of IOLs also holds true for the cornea. He mentioned several advantages of the aspheric hyperprolate cornea but observed that this is not a bilateral solution; he dismissed bifocal refractive treatments as there is limited prospective data, they are irreversible, and dissatisfaction is high. Monovision, he concluded, is currently the only clinically accepted approach.

 

To read OTE's full news coverage of the XXVI congress of the European Society of Cataract & Refractive Surgery, please click here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.